$BTX Lineage Cell Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in Lineage Cell Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Lineage Cell Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Lineage Cell Therapeutics, Inc. for free.
CIK Number: 0000876343
IRS Number: 943127919
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: BTX
Company Address: 2173 SALK AVENUE SUITE 200 CARLSBAD 92008
Phone number: 5105213390
Former name: BIOTIME INC, date of change: 1993-03-28
Market Capitalization: $309.34M
Prev close: $3.06
Average Daily Volume: 261,395
Days Low: $3.00
Year Low: $2.04
Year High: $4.01
Lineage Cell Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2021 | BTX | Lineage Cell Thera ... | Jayasuriya Anula | Director | Option Exercise | A | 2.58 | 90,000 | 232,200 | 90,000 | |
Apr 22 2021 | BTX | Lineage Cell Thera ... | Amin Dipti | Director | Option Exercise | A | 2.28 | 90,000 | 205,200 | 90,000 | |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Option Exercise | M | 0.69 | 6,000 | 4,151 | 39,200 | |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Option Exercise | A | 2.43 | 42,700 | 103,761 | 42,700 | |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Sell | S | 2.23 | 6,000 | 13,380 | 0 | 6 K to 0 (-100.00 %) |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Buy | M | 0.69 | 6,000 | 4,151 | 6,000 | 0 to 6 K |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 77,250 | |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 2.35 | 5,343 | 12,556 | 195,709 | 201.1 K to 195.7 K (-2.66 %) |
Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 2.35 | 15,450 | 36,308 | 201,052 | 185.6 K to 201.1 K (+8.32 %) |
Mar 17 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | A | 2.43 | 1,165,100 | 2,831,193 | 1,165,100 | |
Mar 17 2021 | BTX | Lineage Cell Thera ... | Hogge Gary S. | SVP,Clinical & Medi ... | Option Exercise | A | 2.43 | 419,500 | 1,019,385 | 419,500 | |
Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 92,700 | |
Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 1.76 | 5,343 | 9,404 | 185,602 | 190.9 K to 185.6 K (-2.80 %) |
Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 1.76 | 15,450 | 27,192 | 190,945 | 175.5 K to 190.9 K (+8.80 %) |
Jul 02 2020 | BTX | Lineage Cell Thera ... | BRADSHER NEAL C | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 |
View all Lineage Cell Therapeutics, Inc. insider transactions.